Kaya Holdings KAYS

Kaya Holdings, Inc is a holding company that focuses on wellness and mental health through operations in psychedelic treatment clinics medical and recreational cannabis and CBD products. The company became the first US public company to own and operate a medical cannabis dispensary in 2014. In August 2024 it opened The Sacred Mushroom Psychedelic Treatment Center in Portland Oregon under its subsidiary Fifth Dimension Therapeutics Inc. The firm also maintains a vertically integrated cannabis business that includes cultivation manufacturing and retail dispensary activities. Over the past decade it has produced and sold a broad range of cannabis products such as flower oils vape cartridges and edibles. In addition the company holds two medical marijuana production and processing licenses in Greece to support its international expansion plans. Kaya Holdings, Inc leverages its long standing experience with Oregon regulators to pursue opportunities in the emerging psychedelic treatment sector.

Kaya Holdings, Inc generates revenue primarily from the sale of psychedelic treatment services at The Sacred Mushroom facility and from the sale of cannabis and CBD products through its licensed dispensaries and cultivation operations. The psychedelic treatment center offers supervised psilocybin sessions integration support and wellness activities for clients seeking relief from conditions such as post traumatic stress disorder addiction and eating disorders. Revenue from cannabis operations comes from the retail sale of flower oils vape cartridges infused confections baked goods and beverages at its Oregon dispensary and from wholesale distribution of cultivated flower and extracts in Greece. The company also earns income from licensing its proprietary cannabis strains and from providing extraction and processing services to third party partners. Additionally Kaya Holdings, Inc may receive fees for consulting and training related to psychedelic facilitator certification and compliance with state health authority regulations.

Kaya Holdings, Inc holds a distinctive position as one of the few publicly traded companies that combines licensed psychedelic treatment services with an established cannabis operation. In the psychedelic treatment arena the company competes with specialized therapy providers such as Compass Pathways ATAI Life Sciences and Cybin which focus on developing synthetic psychedelic compounds for pharmaceutical use while Kaya Holdings, Inc emphasizes the delivery of natural psilocybin in a clinical setting. Its early entry into the Oregon psilocybin market and its existing rapport with the Oregon Health Authority give it a regulatory advantage over newer entrants. In the cannabis sector the company faces competition from large multi state operators and numerous local dispensaries yet it differentiates itself through its vertically integrated model that controls cultivation extraction processing and retail sales. The firm’s experience with Greek medical cannabis licenses provides a foothold in the European market where many competitors are still navigating regulatory approvals. Overall Kaya Holdings, Inc leverages its operational history regulatory knowledge and brand portfolio to seek a competitive edge in both emerging industries.

The company serves individuals seeking psychedelic assisted therapy for mental health conditions including post traumatic stress disorder substance addiction anxiety depression and eating disorders who attend supervised sessions at The Sacred Mushroom. Its cannabis dispensary sells to adult consumers aged twenty one and over for both medical and recreational use in Oregon and to licensed wholesalers and processors in Greece. The CBD product line reaches wellness focused consumers who prefer non intoxicating cannabinoid offerings for relaxation and general health. While the filing does not disclose specific client names the customer base consists of qualified patients recreational users and commercial partners engaged in the cultivation distribution and retail of cannabis and psychedelic services.